Skip to main content

Table 4 Results of dosage of cytokines after the administration of OM-174

From: Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

  

Dose level in ug/m2

Median pg/ml

Minimum pg/ml

Maximum pg/ml

IL8

2h

600

2417

54

5000

  

800

3053

443

5000

  

1000

1469

1169

1768

IL6

2h

600

461

3

1521

  

800

1403

150

5000

  

1000

676

296

1058

IL10

2h

600

42

4

138

  

800

90

4

326

  

1000

48

43

52

TNF

1h

600

907

4

1446

  

800

684

4

1970

  

1000

754

485

1024

IL12

2h

600

12

0

35

  

800

0

0

11

  

1000

8

8

9

IL1β

1h

600

34

0

115

  

800

0

0

0

  

1000

13

12

14